Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 2 Interventional

GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

ClinicalTrials.gov ID: NCT00567424

Public ClinicalTrials.gov record NCT00567424. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 5:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Evaluation of Drug Interactions, Safety, Tolerability and Efficacy of GW273225 Add-on Treatment of Partial Seizures, Whether or Not Secondarily Generalized

Study identification

NCT ID
NCT00567424
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 2
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

  • GW273225 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2006
Primary completion
Feb 29, 2008
Completion
Feb 29, 2008
Last update posted
Apr 3, 2013

2006 – 2008

United States locations

U.S. sites
30
U.S. states
19
U.S. cities
29
Facility City State ZIP Site status
GSK Clinical Trials Call Center Phoenix Arizona 85054
GSK Clinical Trials Call Center Sun City Arizona 85351
GSK Clinical Trials Call Center Little Rock Arkansas 72205
GSK Clinical Trials Call Center San Jose California 95128
GSK Clinical Trials Call Center Santa Monica California 90404
GSK Clinical Trials Call Center Jacksonville Florida 32209
GSK Clinical Trials Call Center Tallahassee Florida 32308
GSK Clinical Trials Call Center Tampa Florida 33613
GSK Clinical Trials Call Center Chicago Illinois 60612
GSK Clinical Trials Call Center Springfield Illinois 62704
GSK Clinical Trials Call Center Iowa City Iowa 52242
GSK Clinical Trials Call Center Wichita Kansas 67214
GSK Clinical Trials Call Center Baltimore Maryland 21287
GSK Clinical Trials Call Center Boston Massachusetts 02215
GSK Clinical Trials Call Center Rochester Minnesota 55905
GSK Clinical Trials Call Center Saint Cloud Minnesota 56303
GSK Clinical Trials Call Center Springfield Missouri 65804
GSK Clinical Trials Call Center St Louis Missouri 63310
GSK Clinical Trials Call Center Amherst New York 14226
GSK Clinical Trials Call Center Durham North Carolina 27560
GSK Clinical Trials Call Center Cleveland Ohio 44195
GSK Clinical Trials Call Center Toledo Ohio 43614
GSK Clinical Trials Call Center Medford Oregon 97504
GSK Clinical Trials Call Center Portland Oregon 97225
GSK Clinical Trials Call Center Portland Oregon 97239-3098
GSK Clinical Trials Call Center Dallas Texas 75230
GSK Clinical Trials Call Center Burlington Vermont 05401
GSK Clinical Trials Call Center Richmond Virginia 23219
GSK Clinical Trials Call Center Roanoke Virginia 24018
GSK Clinical Trials Call Center Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00567424, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 3, 2013 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00567424 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →